PTGS2 and central nervous system cancer: The glioma-promoting effects of COX-2 induction are mainly associated with its product, prostaglandin E2 (PGE2) [14], which, in turn, at high levels, favors tumor initiation and progression and is also implicated in the development of therapy resistance [15,16,17].